Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin D receptor 1 (PTGDR1), also known as DP1, is a G protein-coupled receptor that binds prostaglandin D2 (PGD2). It is primarily expressed on immune cells, airway epithelial cells, vascular endothelium, and certain brain regions. DP1 mediates vasodilation, inhibits platelet aggregation, modulates allergic inflammation, and plays a role in cough reflex and reproductive development. Its association with asthma makes it a target of interest for respiratory disease research.
Activation of adenylate cyclase via Gαs subunit, leading to increased intracellular cAMP levels and subsequent activation of protein kinase A (PKA) or PKA-independent signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin D receptor 1 (DP1).